Back to Search

JENNIFER KING

Addiction (Substance Use Disorder) Counselor

NPI: 1306115704IndividualAccepts Medicare

Specialties, Licenses & Credentials

Addiction (Substance Use Disorder) CounselorPrimary

Counselor — Addiction (Substance Use Disorder)

Code: 101YA0400X

25209(NY)

Education

OTHER

Class of 2009

Clinical Trials (2)

2
Linked Trials
0
Recruiting
2
With Results

Impact of Menstrual Cycle on Antiretroviral Pharmacokinetics in Healthy Women

NCT00869960COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR

The Bioequivalence of Atripla in an Oral Liquid Formulation Compared With the Tablet Formulation in Healthy Volunteers

NCT00862823COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR

Research & Publications (1)

A randomized crossover study to determine relative bioequivalence of tenofovir, emtricitabine, and efavirenz (Atripla) fixed-dose combination tablet compared with a compounded oral liquid formulation derived from the tablet.
PMID 22046602·J Acquir Immune Defic Syndr·2011
4-observational

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
10825 BENNETT RD
DUNKIRK, NY 14048

Location

Practice Location

10825 BENNETT RD, DUNKIRK, NY
(716) 363-3550

Quick Facts

NPI
1306115704
Entity Type
Individual
Gender
Female
Medicare
Accepted
Specialties
1
Locations
1
Years in Practice
17
Clinical Trials
2
Publications
1

Are you this provider?

Claim Your Profile